O-69a Phase II induction therapy with docetaxel and carboplatinin NSCLC IIIA/IIIB: FDG-PET response predicts overall and disease free survival
Griesinger, F., Overbeck, T., Schöndube, F., Schmidtberger, H., Andreas, S., Schirren, J., Hemmerlein, B., Keppler, U., Leupold, H., Baum, R.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)80201-6
Date:
July, 2005
File:
PDF, 147 KB
english, 2005